PortfoliosLab logoPortfoliosLab logo
UTHR vs. BKNG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

UTHR vs. BKNG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and Booking Holdings Inc. (BKNG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UTHR achieves a 12.05% return, which is significantly higher than BKNG's -22.63% return. Over the past 10 years, UTHR has outperformed BKNG with an annualized return of 17.67%, while BKNG has yielded a comparatively lower 12.44% annualized return.


UTHR

1D
0.10%
1M
-5.79%
YTD
12.05%
6M
10.52%
1Y
90.80%
3Y*
33.49%
5Y*
24.97%
10Y*
17.67%

BKNG

1D
0.83%
1M
6.66%
YTD
-22.63%
6M
-21.85%
1Y
-23.87%
3Y*
17.23%
5Y*
12.82%
10Y*
12.44%
*Multi-year figures are annualized to reflect compound growth (CAGR)

UTHR vs. BKNG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UTHR
United Therapeutics Corporation
12.05%38.09%60.46%-20.93%28.70%42.35%72.33%-19.12%-26.39%3.15%
BKNG
Booking Holdings Inc.
-22.63%8.59%41.31%76.02%-16.00%7.72%8.45%19.24%-0.88%18.53%

Correlation

The correlation between UTHR and BKNG is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jun 17, 1999

0.23

Over the past year, the correlation between UTHR and BKNG has dropped to 0.01 - well below their long-term average of 0.23, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

UTHR:

$25.77B

BKNG:

$130.96B

EPS

UTHR:

$27.00

BKNG:

$7.60

PE Ratio

UTHR:

20.22

BKNG:

21.71

PEG Ratio

UTHR:

0.66

BKNG:

0.32

PS Ratio

UTHR:

8.21

BKNG:

4.82

Total Revenue (TTM)

UTHR:

$3.17B

BKNG:

$27.69B

Gross Profit (TTM)

UTHR:

$2.74B

BKNG:

$22.16B

EBITDA (TTM)

UTHR:

$1.75B

BKNG:

$9.27B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UTHR vs. BKNG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR
UTHR Risk / Return Rank: 9494
Overall Rank
UTHR Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 9696
Sortino Ratio Rank
UTHR Omega Ratio Rank: 9494
Omega Ratio Rank
UTHR Calmar Ratio Rank: 9797
Calmar Ratio Rank
UTHR Martin Ratio Rank: 9696
Martin Ratio Rank

BKNG
BKNG Risk / Return Rank: 1313
Overall Rank
BKNG Sharpe Ratio Rank: 1111
Sharpe Ratio Rank
BKNG Sortino Ratio Rank: 1313
Sortino Ratio Rank
BKNG Omega Ratio Rank: 1414
Omega Ratio Rank
BKNG Calmar Ratio Rank: 1616
Calmar Ratio Rank
BKNG Martin Ratio Rank: 1010
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTHR vs. BKNG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Booking Holdings Inc. (BKNG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


UTHRBKNGDifference
Sharpe ratioReturn per unit of total volatility

+2.67

Sortino ratioReturn per unit of downside risk

+5.16

Omega ratioGain probability vs. loss probability

1.49

0.89

+0.60

Calmar ratioReturn relative to maximum drawdown

8.58

-0.72

+9.30

Martin ratioReturn relative to average drawdown

20.13

-1.36

+21.49

UTHR vs. BKNG - Sharpe Ratio Comparison

The current UTHR Sharpe Ratio is 1.92, which is higher than the BKNG Sharpe Ratio of -0.75. The chart below compares the historical Sharpe Ratios of UTHR and BKNG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

UTHR vs. BKNG - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, smaller than the maximum BKNG drawdown of -99.32%. Use the drawdown chart below to compare losses from any high point for UTHR and BKNG.


Loading charts...

Drawdown Indicators


UTHRBKNGDifference

Max Drawdown

Largest peak-to-trough decline

-93.18%

-99.32%

+6.14%

Max Drawdown (1Y)

Largest decline over 1 year

-10.64%

-33.35%

+22.71%

Max Drawdown (3Y)

Largest decline over 3 years

-33.00%

-33.35%

+0.35%

Max Drawdown (5Y)

Largest decline over 5 years

-33.00%

-39.53%

+6.53%

Max Drawdown (10Y)

Largest decline over 10 years

-55.56%

-47.77%

-7.79%

Current Drawdown

Current decline from peak

-8.51%

-28.50%

+19.99%

Average Drawdown

Average peak-to-trough decline

-35.31%

-47.05%

+11.74%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.53%

17.53%

-13.00%

Volatility

UTHR vs. BKNG - Volatility Comparison

The current volatility for United Therapeutics Corporation (UTHR) is 5.01%, while Booking Holdings Inc. (BKNG) has a volatility of 6.54%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than BKNG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UTHRBKNGDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.01%

6.54%

-1.53%

Volatility (6M)

Calculated over the trailing 6-month period

25.94%

26.83%

-0.89%

Volatility (1Y)

Calculated over the trailing 1-year period

47.55%

31.94%

+15.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

35.08%

32.26%

+2.82%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.06%

32.45%

+2.61%

Dividends

UTHR vs. BKNG - Dividend Comparison

UTHR has not paid dividends to shareholders, while BKNG's dividend yield for the trailing twelve months is around 0.97%.


PositionTTM20252024
BKNG
Booking Holdings Inc.
0.97%0.72%0.70%
UTHR
United Therapeutics Corporation
0.00%0.00%0.00%

Financials

UTHR vs. BKNG - Financials Comparison

This section allows you to compare key financial metrics between United Therapeutics Corporation and Booking Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B20222023202420252026
781.50M
5.53B
(UTHR) Total Revenue
(BKNG) Total Revenue
Values in USD except per share items

UTHR vs. BKNG - Profitability Comparison

The chart below illustrates the profitability comparison between United Therapeutics Corporation and Booking Holdings Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%20222023202420252026
82.9%
0
Portfolio components
UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.

BKNG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Booking Holdings Inc. reported a gross profit of 0.00 and revenue of 5.53B. Therefore, the gross margin over that period was 0.0%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.

BKNG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Booking Holdings Inc. reported an operating income of 1.27B and revenue of 5.53B, resulting in an operating margin of 23.0%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.

BKNG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Booking Holdings Inc. reported a net income of 1.08B and revenue of 5.53B, resulting in a net margin of 19.6%.


Frequently Asked Questions


UTHR and BKNG have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BKNG has higher volatility (6.54%) compared to UTHR (5.01%). In terms of maximum drawdown, UTHR dropped -93.18% vs BKNG's -99.32%.

UTHR currently has the higher Sharpe Ratio (1.92 vs -0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UTHR and BKNG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer